* Health Catalyst Inc HCAT.OQ reported quarterly adjusted
earnings of 7 cents per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 3 cents. The mean expectation of
fourteen analysts for the quarter was for earnings of 10 cents
per share. Wall Street expected results to range from 5 cents
to 16 cents per share.
* Revenue rose 3.5% to $76.35 million from a year ago;
analysts
expected $76.30 million.
* Health Catalyst Inc's reported EPS for the quarter was a
loss
of 24 cents.
* The company reported a quarterly loss of $14.73 million.
* Health Catalyst Inc shares had fallen by 4.7% this
quarter and
lost 16.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "buy"
Wall Street's median 12-month price target for Health Catalyst
Inc is 11.00
This summary was machine generated from LSEG data November 7 at
04:48 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.10 0.07 Missed
Jun. 30 2024 0.08 0.12 Beat
Mar. 31 2024 0.03 0.05 Beat
Dec. 31 2023 0.00 0.02 Beat